Condensed Consolidated Interim Financial Statements as of September 30, 2018

Bayer Group
Consolidated Statements of Cash Flows

 

 

Q3 2017

 

Q3 2018

 

9M 2017

 

9M 2018

 

 

€ million

 

€ million

 

€ million

 

€ million

Income from continuing operations after income taxes

 

773

 

2,894

 

3,316

 

5,653

Income taxes

 

212

 

851

 

894

 

1,561

Financial result

 

403

 

678

 

1,068

 

870

Income taxes paid

 

(546)

 

(612)

 

(1,530)

 

(1,540)

Depreciation, amortization and impairments

 

581

 

910

 

1,825

 

2,084

Change in pension provisions

 

(114)

 

(54)

 

(259)

 

(225)

(Gains) losses on retirements of noncurrent assets

 

(64)

 

(3,982)

 

(100)

 

(4,042)

Decrease (increase) in inventories

 

(314)

 

36

 

(383)

 

219

Decrease (increase) in trade accounts receivable

 

1,274

 

2,408

 

(37)

 

2,517

(Decrease) increase in trade accounts payable

 

(25)

 

440

 

(870)

 

(102)

Changes in other working capital, other noncash items

 

(277)

 

(1,518)

 

431

 

(2,046)

Net cash provided by (used in) operating activities from continuing operations

 

1,903

 

2,051

 

4,355

 

4,949

Net cash provided by (used in) operating activities from discontinued operations

 

808

 

 

1,510

 

Net cash provided by (used in) operating activities (total)

 

2,711

 

2,051

 

5,865

 

4,949

Cash outflows for additions to property, plant, equipment and intangible assets

 

(557)

 

(659)

 

(1,448)

 

(1,467)

Cash inflows from the sale of property, plant, equipment and other assets

 

96

 

47

 

169

 

129

Cash inflows from divestments

 

362

 

7,349

 

416

 

7,563

Cash inflows from (outflows for) noncurrent financial assets

 

(96)

 

(105)

 

(192)

 

2,883

Cash outflows for acquisitions less acquired cash

 

 

 

(158)

 

(45,316)

Interest and dividends received

 

66

 

55

 

129

 

200

Cash inflows from (outflows for) current financial assets

 

302

 

(285)

 

(1,057)

 

2,427

Net cash provided by (used in) investing activities (total)

 

173

 

6,402

 

(2,141)

 

(33,581)

Capital contributions

 

 

 

 

8,986

Proceeds from shares of Covestro AG

 

1,212

 

 

3,717

 

Dividend payments

 

(3)

 

(3)

 

(2,364)

 

(2,406)

Issuances of debt

 

3,479

 

3,877

 

5,195

 

61,205

Retirements of debt

 

(4,383)

 

(12,057)

 

(5,829)

 

(40,741)

Interest paid including interest-rate swaps

 

(338)

 

(349)

 

(727)

 

(793)

Interest received from interest-rate swaps

 

19

 

18

 

56

 

400

Cash outflows for the purchase of additional interests in subsidiaries

 

(23)

 

(47)

 

(23)

 

(47)

Net cash provided by (used in) financing activities (total)

 

(37)

 

(8,561)

 

25

 

26,604

Change in cash and cash equivalents due to business activities (total)

 

2,847

 

(108)

 

3,749

 

(2,028)

Cash and cash equivalents at beginning of year

 

2,773

 

5,011

 

1,899

 

7,436

Change in cash and cash equivalents due to changes in scope of consolidation

 

 

 

 

1

Change in cash and cash equivalents due to exchange rate movements

 

(65)

 

(53)

 

(93)

 

(559)

Cash and cash equivalents at end of year

 

5,555

 

4,850

 

5,555

 

4,850

Compare to Last Year